A detailed history of Evelyn Partners Investment Management LLP transactions in Eli Lilly & CO stock. As of the latest transaction made, Evelyn Partners Investment Management LLP holds 5,055 shares of LLY stock, worth $5.18 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
5,055
Previous 5,269 4.06%
Holding current value
$5.18 Million
Previous $3.98 Billion 3.14%
% of portfolio
0.11%
Previous 0.16%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$625.65 - $812.69 $133,889 - $173,915
-214 Reduced 4.06%
5,055 $3.86 Billion
Q2 2025

Aug 12, 2025

BUY
$713.71 - $898.95 $3.5 Million - $4.41 Million
4,909 Added 1363.61%
5,269 $3.98 Billion
Q1 2025

Aug 04, 2025

BUY
$725.72 - $929.72 $261,259 - $334,699
360 New
360 $4.04 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $974B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Evelyn Partners Investment Management LLP Portfolio

Follow Evelyn Partners Investment Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evelyn Partners Investment Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Evelyn Partners Investment Management LLP with notifications on news.